Skip to main content
MAIA Biotechnology, Inc. logo

MAIA Biotechnology, Inc. — Investor Relations & Filings

Ticker · MAIA ISIN · US5526411021 US Manufacturing
Filings indexed 456 across all filing types
Latest filing 2026-05-22 Regulatory Filings
Country US United States of America
Listing US MAIA

About MAIA Biotechnology, Inc.

https://maiabiotech.com/

MAIA Biotechnology, Inc. is a clinical-stage immuno-oncology company focused on the development and commercialization of targeted therapies for cancer. The company develops potential first-in-class drugs with novel mechanisms of action, specializing in telomere-targeting agents. Its therapeutic approach utilizes immunotherapies designed to target telomeres in cancer cells. The company's pipeline products are currently under clinical investigation.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings
2026-05-22 English
DEFA14A
Proxy Solicitation & Information Statement
2026-05-19 English
8-K
Regulatory Filings
2026-05-14 English
424B5
Prospectus
2026-05-14 English
10-Q - MAIA Biotechnology, Inc. (0001878313) (Filer)
Interim / Quarterly Report
2026-05-11 English
8-K - MAIA Biotechnology, Inc. (0001878313) (Filer)
Regulatory Filings
2026-04-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.